 |
Song IS
|
The Substrate Dependent Effect of Genetic Polymorphism of SLCO1B1; the Contribution of Transporting Activity Changes by SLCO1B1*15 (ÃÊû°¿¬ )
|
|
2008 ´ëÇѾàÇÐȸ º½ ±¹Á¦Çмú´ëȸ / 2008.04.30 - 05.03 / Á¦ÁÖ±¹Á¦ÄÁº¥¼Ç¼¾ÅÍ [LINK ] |
|
 |
|
|
 |
Shin JG
|
ÀÓ»ó½ÃÇè¼¾ÅÍÀÇ ¼º°øÀûÀÎ ¿î¿µ »ç·Ê (ÃÊû°¿¬ )
|
|
2008³âµµ Á¦2ȸ ÀÓ»ó½ÃÇè½É»çÀ§¿øÈ¸ ¹× Àӻ󿬱¸¼¾ÅÍ ¼¼¹Ì³ª / À»Áö´ëÇк´¿ø 2Ãþ Á¦1¼¼¹Ì³ª½Ç / 2008.02.22 [LINK ] |
|
 |
|
|
 |
Oh S
|
Small molecule-based modulaltion of the Wnt/b-catein signaling pathway (ÃÊû°¿¬ )
|
|
Çѱ¹ºÐÀÚ¼¼Æ÷»ý¹°ÇÐȸ Á¦19ȸ µ¿°èÇмú´ëȸ / °¿øµµ ¿ëÆò¸®Á¶Æ® ±×¸°ÇǾÆÄܵµ / 2008.02.13-15 [LINK ] |
|
 |
|
|
 |
Lee SJ
|
Genetic polymorphisms of human CYP3As and their clinical consequences (ÃÊû°¿¬ )
|
|
Á¦41ȸ »ý¸í°úÇבּ¸¼Ò ¼¼¹Ì³ª / °¿ø´ëÇб³ ÀÚ¿¬´ë °øµ¿ ¼¼¹Ì³ª½Ç / 2007.12.6 [LINK ] |
|
 |
|
|
 |
Song IS
|
Pharmacokinetic consequences and high throughput evaluation of genetic polymorphism s in drug transporters (ÃÊû°¿¬ )
|
|
International Conference of the Korean Society of Pharmaceutical Sciences and Technology / AT Center / 2007.11.22-23 [LINK ] |
|
 |
|
|
 |
Shin JG
|
Pharmacogenetics and genomics for the personalized pharmacotherapy ( )
|
|
Á¦35Â÷ ´ëÇÑÀÇÇÐÀ¯ÀüÇÐȸ Ãß°èÇмú´ëȸ / ¾ÆÁִ뺴¿ø º°°ü ´ë°´ç / 2007.11.16 [LINK ] |
|
 |
|
|
 |
Liu KH
|
Stereoselectivity issue in drug metabolism and drug interaction study ( )
|
|
2007³âµµ Á¦16Â÷ ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ ¹× Çѱ¹Á¦¾àÀÇÇÐȸ Ãß°èÇмú´ëȸ / ±¤ÁÖ¹«µîÆÄũȣÅÚ / 2007.11.8-9 [LINK ] |
|
 |
|
|
 |
Oh S
|
Chemical genetic-based identification of PKC as a nefative regulator of Wnt/b-catenin pathway (ÃÊû°¿¬ )
|
|
The Korea-Japan Joint Symposium on Wnt signaling and human diseases / ¿¬¼¼´ë »õõ³â°ü ´ë°´ç / 2007.10.25-26 [LINK ] |
|
 |
|
|
 |
Shin JG
|
½Å¾à°³¹ß°ú ÀÓ»ó½ÃÇè (ÃÊû°¿¬ )
|
|
Á¦2ȸ Àӻ󿬱¸ÄÚµð³×ÀÌÅÍ ±³À° / ÀÎÁ¦´ë ºÎ»ê¹éº´¿ø Pµ¿ 11Ãþ °´ç / 2007.09.29 [LINK ] |
|
 |
|
|
 |
Shin JG
|
Clinical Pharmacology Education and Training ( )
|
|
Bio Korea 2007 / COEX Seoul / 2007.09.14 [LINK ] |
|
 |
|